黑色素瘤  TIL疗法

https://mp.weixin.qq.com/s/uUb9OcVhJOEDaJNveMtLhQ

http://www.pubmedplus.cn/P/SearchQuickResult?wd=a91bd280-c8cf-424e-81a7-c86437d5099f

• 1. Adoptive tumor infiltrating lymphocyte transfer as personalized immunotherapy.

  Ines Diaz-Cano,Luis Paz-Ares,Itziar Otano

  H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre/Spanish National Cancer Research Center (CNIO), Madrid, Spain.

  iotanoan@alumni.unav.es

  Int Rev Cell Mol Biol (P 1937-6448 E 1937-6448) H指数：106 2022 年 370 卷 163-192 页

  PMID：35798505 相似文献

  文摘 DOI链接 Elsevier Science

• 2. Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness.

  Melanie Lindenberg,Valesca Retèl,Maartje Rohaan,Joost van den Berg,John Haanen,Wim van Harten

  Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.

  w.v.harten@nki.nl

  BMC Cancer (P 1471-2407 E 1471-2407) H指数：111 2020 年 20 卷 1 期 712 页

  PMID：32736535 相似文献

  文摘 DOI链接 PubMed CentralEurope PubMed CentralBioMed Central

• 3. Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product.

  Melanie A Lindenberg,Valesca P Retèl,Joost H van den Berg,Marnix H Geukes Foppen,John B Haanen,Wim H van Harten

  Division of Psychosocial Research and Epidemiology.

  J Immunother (P 1537-4513 E 1524-9557) H指数：89 2018 年 41 卷 9 期 413-425 页

  PMID：30300260 相似文献

  文摘 DOI链接

http://www.pubmedplus.cn/P/SearchQuickResult?wd=aa420940-11bb-45aa-a470-6f9a11036834

• 主题词

• 记录数占%